Astellas buys US biotech Xyphos for $665M

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Astellas Pharma Inc acquired the US biotech firm Xyphos Biosciences amid its immuno-oncology business expansion, in a deal valued at about $665M.
Back to articles

Actual Topics

Fri, 27 Dec 2019 14:25:58 GMT

Colombia names Galindo as CB's board member

On Friday, the President Ivan Duque has named Arturo Galindo as the Colombian central bank's new board member, succeeding Jose Antonio Ocampo, following his resignation last week.

Fri, 27 Dec 2019 12:21:47 GMT

Hyundai Development cloess $2.2B purchase of Asiana Airlines

On Friday, Hyundai Development, the South Korean builder, announced that its consortium closed a $2.16B acquisition of the majority stake in the second-largest carrier in the country, Asiana Airlines.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.